非增强MRA与增强CTA在DIEP皮瓣规划中的非劣效性队列研究
本研究纳入131例延迟单侧DIEP皮瓣乳房再造女性,比较优化非增强MRA(n=81)与增强CTA(n=50)的规划效果。MRA组手术时间和蒂部解剖时间显著缩短,筋膜切口更短,诊断准确率、敏感性和阳性预测值组间无显著差异,灌注相关并发症率无显著差异。结论认为优化非增强MRA在DIEP皮瓣规划中不劣于CTA。
要点
- 非增强MRA组手术时间333.0±30.4 min,显著短于CTA组348.9±28.8 min(P=.003)。
- 非增强MRA组蒂部解剖时间35.7±8.2 min,显著短于CTA组40.1±5.9 min(P<.001)。
- 两组诊断准确率98.8% vs 99.6%(P=.4145),灌注相关并发症率无显著差异。
核心结论
- 优化非增强MRA是DIEP皮瓣规划中临床可靠、不劣于CTA的替代方案,并可缩短手术和蒂部解剖时间。
研究设计与样本
- 队列研究纳入131例延迟单侧DIEP皮瓣乳房再造女性,平均年龄45.6±7.1岁,BMI 28.5±3.9 kg/m2。
- Group 1(n=81)接受优化非增强MRA,Group 2(n=50)接受标准增强CTA。
主要发现
- MRA组手术时间333.0±30.4 min vs CTA组348.9±28.8 min(P=.003)。
- MRA组蒂部解剖时间35.7±8.2 min vs CTA组40.1±5.9 min(P<.001)。
- MRA组筋膜切口长度9.1±1.5 cm vs CTA组10.6±1.6 cm(P=.025)。
- 诊断准确率98.8% vs 99.6%(P=.4145),敏感性98.3% vs 100.0%,阳性预测值97.5% vs 98.7%。
- 穿支定位平均差异7.38±2.59 mm vs 6.96±2.34 mm(P=.238),灌注相关并发症率组间无显著差异(P>.05)。
临床怎么用
- 在延迟单侧DIEP皮瓣乳房再造规划中,可考虑采用优化非增强MRA替代增强CTA,以避免碘对比剂和电离辐射暴露。
局限性
- 证据等级为3级(治疗性)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Contrast-enhanced computed tomography angiography (CTA) is considered the "gold standard" in deep inferior epigastric perforator (DIEP) planning, despite its use of iodine-based contrast and ionizing radiation exposure. In contrast, magnetic resonance angiography (MRA) provides a radiation-free alternative, but conventional MRA requires the use of an expensive and potentially harmful gadolinium-based contrast agent. The development of contrast-free MRA protocols that preserve perforator mapping accuracy represents a promising area of investigation in DIEP flap planning. OBJECTIVES: The aim of this study was to evaluate whether an optimized noncontrast MRA protocol is noninferior to contrast-enhanced CTA in planning for delayed DIEP flap breast reconstruction (BR). METHODS: This cohort study included 131 women (mean age 45.6 ± 7.1; BMI 28.5 ± 3.9 kg/m2), who underwent delayed unilateral DIEP flap BR. Group 1 (n = 81) underwent a noncontrast MRA with tailored preprocedural preparation, positioning, and scanning. Group 2 (n = 50) underwent standard contrast-enhanced CTA. RESULTS: MRA significantly reduced operative time (333.0 ± 30.4 vs 348.9 ± 28.8 min; P = .003) and pedicle dissection time (35.7 ± 8.2 vs 40.1 ± 5.9 min; P < .001). The mean fascial incision length was shorter in the MRA group (9.1 ± 1.5 vs 10.6 ± 1.6 cm; P = .025). Diagnostic accuracy was 98.8% vs 99.6% (P = .4145); sensitivity was 98.3% vs 100.0%, and positive predictive value was 97.5% vs 98.7%, for MRA and CTA, respectively. The mean localization difference (ΔL) was 7.38 ± 2.59 vs 6.96 ± 2.34 mm (P = .238). Perfusion-related complication rates did not differ significantly between groups (P > .05). No significant differences were observed in baseline perforator characteristics. CONCLUSIONS: Optimized noncontrast MRA is a clinically reliable, noninferior alternative to CTA in DIEP flap planning, with additional advantages of reduced operative and dissection times. LEVEL OF EVIDENCE: 3 (THERAPEUTIC): For image description, please refer to the figure legend and surrounding text.
引用
- Melnikov DV, Abdeeva EI, Cotofana S, et al. Noncontrast Magnetic Resonance Angiography vs Contrast-Enhanced Computed Tomography in Deep Inferior Epigastric Perforator Flap Planning: A 4-year Noninferiority Cohort Study. Aesthet Surg J. 2026. PMID: 42413036. doi:10.1093/asj/sjag140
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。